Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Glioma | Correction

Correction to: Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas

Authors: Faiqa Mudassar, Han Shen, Geraldine O’Neill, Eric Hau

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Correction to: J Exp Clin Cancer Res 39, 208 (2020) …

Mudassar F, Shen H, O’Neill G, et al. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J Exp Clin Cancer Res. 2020;39:208 https://doi.org/10.1186/s13046-020-01724-6.CrossRef

Title: Correction to: Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Authors: Faiqa Mudassar
Han Shen
Geraldine O’Neill
Eric Hau
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Glioma
Glioma
Glioma
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-02161-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320

Cellular based immunotherapy for primary liver cancer

Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer